Webinar: Long COVID - A Crisis for Neurology - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

News and Events

null Webinar: Long COVID - A Crisis for Neurology

Webinar - Long Covid: A Crisis for Neurology

Long COVID presents with a multitude of heterogeneous symptoms predominantly neurological in nature. It poses major challenges in the diagnosis and treatment. The pathological corelates and underlying mechanisms are poorly understood. This talk will describe our current knowledge of the illness and the opportunities for research that could have a major impact on this and related illnesses.

Speaker:   
Avindra Nath, MD
Chief, Section of Infections of the Nervous System
Clinical Director, National Institute of Neurological Disorders and Stroke
National Institutes of Health

When: 
March 28th, 2023
2PM ET 

Watch the recording >

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, Cimit has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.